Cargando…
Decreased Blood Level of MFSD2a as a Potential Biomarker of Alzheimer’s Disease
The protein Major Facilitator Superfamily Domain containing 2A (MFSD2a) was recently described as the primary carrier for docosahexaenoic acid (DHA) into the brain. Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by lower DHA levels in blood lipids. The aim of this...
Autores principales: | Sánchez-Campillo, María, Ruiz-Pastor, María José, Gázquez, Antonio, Marín-Muñoz, Juan, Noguera-Perea, Fuensanta, Ruiz-Alcaraz, Antonio J., Manzanares-Sánchez, Salvadora, Antúnez, Carmen, Larqué, Elvira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981746/ https://www.ncbi.nlm.nih.gov/pubmed/31861865 http://dx.doi.org/10.3390/ijms21010070 |
Ejemplares similares
-
Child Head Circumference and Placental MFSD2a Expression Are Associated to the Level of MFSD2a in Maternal Blood During Pregnancy
por: Sánchez-Campillo, María, et al.
Publicado: (2020) -
Insulin Treatment May Alter Fatty Acid Carriers in Placentas from Gestational Diabetes Subjects
por: Ruiz-Palacios, Maria, et al.
Publicado: (2017) -
Calcifediol During Pregnancy Improves Maternal and Fetal Availability of Vitamin D Compared to Vitamin D3 in Rats and Modifies Fetal Metabolism
por: Gázquez, Antonio, et al.
Publicado: (2022) -
Towards an Optimized Fetal DHA Accretion: Differences on Maternal DHA Supplementation Using Phospholipids vs. Triglycerides during Pregnancy in Different Models
por: Gázquez, Antonio, et al.
Publicado: (2021) -
Adiponectin agonist treatment in diabetic pregnant rats
por: Gázquez, Antonio, et al.
Publicado: (2021)